Clinical Trial Update: Neo-adjuvant Erbitux-based Chemotherapy for Locally Advanced Oral/Oropharyngeal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update on neoadjuvant Erbitux-based chemotherapy for locally advanced oral/oropharyngeal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Neoplasm
• Oral Cancer
• Oropharyngeal Carcinoma

Drugs mentioned

• ERBITUX (cetuximab)

Snippet

Sponsor: Shanghai Jiao Tong University School of Medicine | Conditions: Locally Advanced Malignant Neoplasm, Oral Cancer | Phase 2 | Status: COMPLETED